Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. (KYMR) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 434 transactions totaling $517.9M, demonstrating a bearish sentiment with -$3.3M in net insider flow. The most recent transaction on Dec 31, 2025 involved a sale of 23,986 shares valued at $1.9M.
KYMR Insider Activity Summary
Who Is Buying KYMR Stock?
No significant insider buying has been recorded for KYMR in the recent period.
Who Is Selling KYMR Stock?
No significant insider selling has been recorded for KYMR in the recent period.
Is Kymera Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KYMR is bearish with an Insider Alignment Score of 50/100 and a net flow of -$3.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KYMR Frequently Asked Questions
Understanding KYMR Insider Activity
Insider trading at Kymera Therapeutics, Inc. (KYMR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading KYMR stock, having executed 434 transactions in the past 90 days. The most active insider is Felix Baker (Executive), who has made 2 transactions totaling $172.5M.
Related Tools
Track Kymera Therapeutics, Inc. Insider Activity
Get notified when executives and directors at KYMR file new Form 4 transactions